Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB

J Med Microbiol. 2017 Jun;66(6):833-841. doi: 10.1099/jmm.0.000456.

Abstract

Purpose: It is known that the arnB (or pmrH) gene encoding uridine 5'-(beta-1-threo-pentapyranosyl-4-ulose diphosphate) aminotransferase plays a critical role in colistin resistance in Pseudomonas aeruginosa through the addition of 4-amino-4-deoxy-l-arabinose (l-Ara4N) to lipid A. In this study, we attempted to obtain a colistin-resistant mutant from an arnB-deleted mutant through exposure to colistin.

Methodology: We constructed an arnB deletion mutant (P5ΔarnB :: nptIII) from a colistin-susceptible strain (P5) by allelic replacement mutagenesis, and colistin-resistant mutants were selected in vitro using P5 and P5ΔarnB :: nptIII. The growth rate, lipid A structure, biofilm-forming activity and cell viability in diverse stressful conditions (osmotic, oxidative, acidic and heat stress) were investigated. Expression of phoP, pmrA, parR, and cprR was evaluated by qRT-PCR.

Results: An arnB deletion mutant was shown to develop colistin resistance through the addition of l-Ara4N to lipid A, despite a low survival rate (over 1000-fold lower than that of the wild-type strain) in the media with colistin. Two colistin-resistant mutants showed higher survival rates than colistin-susceptible strains against 5 % NaCl. In the presence of acidic and heat stress, P5ΔarnB :: nptIII-CstR exhibited higher survival rates during conditions of 1 % HCl and 42 °C than the other strains. Both phoP and pmrA genes were overexpressed significantly in both colistin-resistant mutants, but parR and cprR genes were not.

Conclusion: We revealed that colistin resistance could be developed despite arnB deletion in P. aeruginosa through the addition of l-Ara4N to lipid A, which was accompanied by diverse physiological changes.

MeSH terms

  • Amino Sugars / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics*
  • Colistin / pharmacology*
  • Drug Resistance, Bacterial* / genetics
  • Genes, Bacterial
  • Lipid A / metabolism
  • Microbial Sensitivity Tests
  • Microbial Viability / drug effects
  • Mutation
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / genetics*
  • Stress, Physiological

Substances

  • Amino Sugars
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Lipid A
  • pmrA protein, Bacteria
  • PhoP protein, Bacteria
  • 4-amino-4-deoxyarabinose
  • Colistin